Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniella Beckman currently holds 53,283 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniella Beckman has been a net seller of BPMC stock. They have purchased $0 and sold $46.9K worth of shares.
Daniella Beckman's most recent insider trade was on Jun 11, 2026, when they sold 53,283 shares at $0.00 per share.
Daniella Beckman serves as Executive at Blueprint Medicines Corp (BPMC). They have executed 14 insider transactions totaling $46.9K over their tenure at the company.
Daniella Beckman holds the position of Executive at Blueprint Medicines Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Daniella Beckman has shown a selling trading pattern, with $0 in total purchases and $46.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniella Beckman was on Feb 6, 2024, when they sold $24.0K worth of TNGX shares. This transaction involved 1,908 shares at $12.56 per share.
Daniella Beckman currently owns 53,283 shares of Blueprint Medicines Corp (BPMC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniella Beckman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniella Beckman has 14 Form 4 filings on record as an insider at Blueprint Medicines Corp.
Set alerts for Daniella Beckman and 40,000+ other insiders.